FINE FOODS & PHARMACEUTICALS (FF.MI) Fundamental Analysis & Valuation

BIT:FF • IT0005215329

Current stock price

8.26 EUR
+0.06 (+0.73%)
Last:

This FF.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. FF.MI Profitability Analysis

1.1 Basic Checks

  • FF had positive earnings in the past year.
  • In the past year FF had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: FF reported negative net income in multiple years.
  • FF had a positive operating cash flow in 4 of the past 5 years.
FF.MI Yearly Net Income VS EBIT VS OCF VS FCFFF.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

  • FF has a better Return On Assets (6.89%) than 84.21% of its industry peers.
  • With an excellent Return On Equity value of 13.58%, FF belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
  • The Return On Invested Capital of FF (9.84%) is better than 84.21% of its industry peers.
  • FF had an Average Return On Invested Capital over the past 3 years of 3.16%. This is significantly below the industry average of 9.20%.
  • The 3 year average ROIC (3.16%) for FF is below the current ROIC(9.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.89%
ROE 13.58%
ROIC 9.84%
ROA(3y)-0.42%
ROA(5y)0.94%
ROE(3y)-1.24%
ROE(5y)0.96%
ROIC(3y)3.16%
ROIC(5y)3.16%
FF.MI Yearly ROA, ROE, ROICFF.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • With a Profit Margin value of 5.07%, FF is not doing good in the industry: 68.42% of the companies in the same industry are doing better.
  • The Operating Margin of FF (7.85%) is worse than 78.95% of its industry peers.
  • In the last couple of years the Operating Margin of FF has grown nicely.
  • FF has a Gross Margin (34.77%) which is comparable to the rest of the industry.
  • FF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.85%
PM (TTM) 5.07%
GM 34.77%
OM growth 3Y24.97%
OM growth 5Y2.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.32%
GM growth 5Y2.27%
FF.MI Yearly Profit, Operating, Gross MarginsFF.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. FF.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FF is creating some value.
  • The number of shares outstanding for FF remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, FF has more shares outstanding
  • The debt/assets ratio for FF has been reduced compared to a year ago.
FF.MI Yearly Shares OutstandingFF.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FF.MI Yearly Total Debt VS Total AssetsFF.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 2.92 indicates that FF is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • FF has a Altman-Z score (2.92) which is in line with its industry peers.
  • FF has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • FF has a Debt to Equity ratio of 0.44. This is in the better half of the industry: FF outperforms 78.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 2.92
ROIC/WACC1.11
WACC8.85%
FF.MI Yearly LT Debt VS Equity VS FCFFF.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 1.67 indicates that FF should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.67, FF is doing good in the industry, outperforming 68.42% of the companies in the same industry.
  • FF has a Quick Ratio of 1.07. This is a normal value and indicates that FF is financially healthy and should not expect problems in meeting its short term obligations.
  • FF has a Quick ratio of 1.07. This is in the better half of the industry: FF outperforms 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.07
FF.MI Yearly Current Assets VS Current LiabilitesFF.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. FF.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 147.03% over the past year.
  • Looking at the last year, FF shows a small growth in Revenue. The Revenue has grown by 1.78% in the last year.
  • The Revenue has been growing by 8.83% on average over the past years. This is quite good.
EPS 1Y (TTM)147.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.62%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y7.75%
Revenue growth 5Y8.83%
Sales Q2Q%12.18%

3.2 Future

  • Based on estimates for the next years, FF will show a very strong growth in Earnings Per Share. The EPS will grow by 27.39% on average per year.
  • FF is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.10% yearly.
EPS Next Y45.43%
EPS Next 2Y35.99%
EPS Next 3Y29.5%
EPS Next 5Y27.39%
Revenue Next Year4.3%
Revenue Next 2Y8.2%
Revenue Next 3Y8.73%
Revenue Next 5Y12.1%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FF.MI Yearly Revenue VS EstimatesFF.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
FF.MI Yearly EPS VS EstimatesFF.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

7

4. FF.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.28, the valuation of FF can be described as very reasonable.
  • FF's Price/Earnings ratio is rather cheap when compared to the industry. FF is cheaper than 94.74% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, FF is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.83, the valuation of FF can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FF indicates a rather cheap valuation: FF is cheaper than 94.74% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, FF is valued a bit cheaper.
Industry RankSector Rank
PE 9.28
Fwd PE 11.83
FF.MI Price Earnings VS Forward Price EarningsFF.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, FF is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.21
FF.MI Per share dataFF.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • FF has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as FF's earnings are expected to grow with 29.50% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y35.99%
EPS Next 3Y29.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. FF.MI Dividend Analysis

5.1 Amount

  • FF has a Yearly Dividend Yield of 1.97%.
  • Compared to an average industry Dividend Yield of 0.60, FF pays a better dividend. On top of this FF pays more dividend than 100.00% of the companies listed in the same industry.
  • FF's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.97%

5.2 History

  • The dividend of FF has a limited annual growth rate of 4.24%.
Dividend Growth(5Y)4.24%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • FF pays out 18.40% of its income as dividend. This is a sustainable payout ratio.
  • FF's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP18.4%
EPS Next 2Y35.99%
EPS Next 3Y29.5%
FF.MI Yearly Income VS Free CF VS DividendFF.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M
FF.MI Dividend Payout.FF.MI Dividend Payout, showing the Payout Ratio.FF.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FF.MI Fundamentals: All Metrics, Ratios and Statistics

FINE FOODS & PHARMACEUTICALS

BIT:FF (3/20/2026, 5:23:37 PM)

8.26

+0.06 (+0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-11
Earnings (Next)05-06
Inst Owners12.21%
Inst Owner ChangeN/A
Ins Owners53.17%
Ins Owner ChangeN/A
Market Cap182.22M
Revenue(TTM)373.66M
Net Income(TTM)18.62M
Analysts86.15
Price Target13.12 (58.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.97%
Yearly Dividend0.12
Dividend Growth(5Y)4.24%
DP18.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.29%
PT rev (3m)4.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.5%
EPS NY rev (3m)-5.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-1.24%
Valuation
Industry RankSector Rank
PE 9.28
Fwd PE 11.83
P/S 0.5
P/FCF N/A
P/OCF 4.94
P/B 1.33
P/tB 1.47
EV/EBITDA 5.21
EPS(TTM)0.89
EY10.77%
EPS(NY)0.7
Fwd EY8.45%
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)1.67
OCFY20.25%
SpS16.64
BVpS6.22
TBVpS5.62
PEG (NY)0.2
PEG (5Y)N/A
Graham Number11.16
Profitability
Industry RankSector Rank
ROA 6.89%
ROE 13.58%
ROCE 14.28%
ROIC 9.84%
ROICexc 11.04%
ROICexgc 11.92%
OM 7.85%
PM (TTM) 5.07%
GM 34.77%
FCFM N/A
ROA(3y)-0.42%
ROA(5y)0.94%
ROE(3y)-1.24%
ROE(5y)0.96%
ROIC(3y)3.16%
ROIC(5y)3.16%
ROICexc(3y)3.64%
ROICexc(5y)4.57%
ROICexgc(3y)4.02%
ROICexgc(5y)5.02%
ROCE(3y)4.59%
ROCE(5y)4.62%
ROICexgc growth 3Y13.05%
ROICexgc growth 5Y-1.19%
ROICexc growth 3Y17.44%
ROICexc growth 5Y-2.63%
OM growth 3Y24.97%
OM growth 5Y2.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.32%
GM growth 5Y2.27%
F-Score7
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA 1.35
Cap/Depr 262.56%
Cap/Sales 11.33%
Interest Coverage 250
Cash Conversion 82.61%
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.07
Altman-Z 2.92
F-Score7
WACC8.85%
ROIC/WACC1.11
Cap/Depr(3y)145.26%
Cap/Depr(5y)138.08%
Cap/Sales(3y)9.82%
Cap/Sales(5y)9.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)147.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.62%
EPS Next Y45.43%
EPS Next 2Y35.99%
EPS Next 3Y29.5%
EPS Next 5Y27.39%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y7.75%
Revenue growth 5Y8.83%
Sales Q2Q%12.18%
Revenue Next Year4.3%
Revenue Next 2Y8.2%
Revenue Next 3Y8.73%
Revenue Next 5Y12.1%
EBIT growth 1Y70.93%
EBIT growth 3Y34.65%
EBIT growth 5Y11.14%
EBIT Next Year146.31%
EBIT Next 3Y46.6%
EBIT Next 5Y31.96%
FCF growth 1Y57.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y568.5%
OCF growth 3YN/A
OCF growth 5Y19.07%

FINE FOODS & PHARMACEUTICALS / FF.MI Fundamental Analysis FAQ

What is the fundamental rating for FF stock?

ChartMill assigns a fundamental rating of 6 / 10 to FF.MI.


Can you provide the valuation status for FINE FOODS & PHARMACEUTICALS?

ChartMill assigns a valuation rating of 7 / 10 to FINE FOODS & PHARMACEUTICALS (FF.MI). This can be considered as Undervalued.


Can you provide the profitability details for FINE FOODS & PHARMACEUTICALS?

FINE FOODS & PHARMACEUTICALS (FF.MI) has a profitability rating of 6 / 10.


Can you provide the financial health for FF stock?

The financial health rating of FINE FOODS & PHARMACEUTICALS (FF.MI) is 4 / 10.


Can you provide the expected EPS growth for FF stock?

The Earnings per Share (EPS) of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to grow by 45.43% in the next year.